2021/08/03 ALA-1000 Receive notice of patent allowance from Japan Patent Office (JPO), Application No. 特願2019-535434.Post author:alarpharmPost published:9 . 8 . 2021Post category:Media releases You Might Also Like 2024/02/05 ALA-2000 has received a notice of allowance from The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), India, after examination. (Patent Application No. 501360) 29 . 2 . 2024 2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024 2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022 2021/04/30 ALA-1000 was granted by Intellectual Property Office of New Zealand.Patent No. 750367. 3 . 5 . 2021 2020/08/21 Alar Pharmaceuticals Inc. Completes Pre-IND Meeting with US FDA for ALA-3000 24 . 8 . 2020
2024/02/05 ALA-2000 has received a notice of allowance from The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), India, after examination. (Patent Application No. 501360) 29 . 2 . 2024
2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024
2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022
2021/04/30 ALA-1000 was granted by Intellectual Property Office of New Zealand.Patent No. 750367. 3 . 5 . 2021
2020/08/21 Alar Pharmaceuticals Inc. Completes Pre-IND Meeting with US FDA for ALA-3000 24 . 8 . 2020